These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34531750)

  • 1. Glucose Metabolism Reprogramming of Regulatory T Cells in Concanavalin A-Induced Hepatitis.
    Huang C; Shen Y; Shen M; Fan X; Men R; Ye T; Yang L
    Front Pharmacol; 2021; 12():726128. PubMed ID: 34531750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble Fgl2 restricts autoimmune hepatitis progression via suppressing Tc17 and conventional CD8+ T cell function.
    Ai G; Yan W; Yu H; Xiao F; Xi D; Ma K; Huang J; Luo X; Wan X; Ning Q
    J Gene Med; 2018 Jul; 20(7-8):e3023. PubMed ID: 29756667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adoptive transfer of regulatory T cells stimulated by Allogeneic Hepatic Stellate Cells mitigates liver injury in mice with concanavalin A-induced autoimmune hepatitis.
    Huang H; Deng Z
    Biochem Biophys Res Commun; 2019 Apr; 512(1):14-21. PubMed ID: 30853178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered aryl-hydrocarbon-receptor signalling affects regulatory and effector cell immunity in autoimmune hepatitis.
    Vuerich M; Harshe R; Frank LA; Mukherjee S; Gromova B; Csizmadia E; Nasser IAM; Ma Y; Bonder A; Patwardhan V; Robson SC; Longhi MS
    J Hepatol; 2021 Jan; 74(1):48-57. PubMed ID: 32663496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Imbalance between Foxp3
    Liang M; Liwen Z; Yun Z; Yanbo D; Jianping C
    J Immunol Res; 2018; 2018():3753081. PubMed ID: 30050955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foxp3⁺ Treg Cells Are Associated with Pathological Process of Autoimmune Hepatitis by Activating Methylation Modification in Autoimmune Hepatitis Patients.
    Chen J; Liu W; Zhu W
    Med Sci Monit; 2019 Aug; 25():6204-6212. PubMed ID: 31422415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver homing of clinical grade Tregs after therapeutic infusion in patients with autoimmune hepatitis.
    Oo YH; Ackrill S; Cole R; Jenkins L; Anderson P; Jeffery HC; Jones N; Jeffery LE; Lutz P; Wawman RE; Athwal AK; Thompson J; Gray J; Guo K; Barton D; Hirschfield GM; Wong T; Guest P; Adams DH
    JHEP Rep; 2019 Oct; 1(4):286-296. PubMed ID: 32039380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency.
    Peiseler M; Sebode M; Franke B; Wortmann F; Schwinge D; Quaas A; Baron U; Olek S; Wiegard C; Lohse AW; Weiler-Normann C; Schramm C; Herkel J
    J Hepatol; 2012 Jul; 57(1):125-32. PubMed ID: 22425700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrahepatic status of regulatory T cells in autoimmune liver diseases and chronic viral hepatitis.
    Sakaki M; Hiroishi K; Baba T; Ito T; Hirayama Y; Saito K; Tonoike T; Kushima M; Imawari M
    Hepatol Res; 2008 Apr; 38(4):354-61. PubMed ID: 18021223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies.
    Taubert R; Hardtke-Wolenski M; Noyan F; Wilms A; Baumann AK; Schlue J; Olek S; Falk CS; Manns MP; Jaeckel E
    J Hepatol; 2014 Nov; 61(5):1106-14. PubMed ID: 24882050
    [TBL] [Abstract][Full Text] [Related]  

  • 11.  Assessment of intrahepatic regulatory T cells in children with autoimmune hepatitis.
    Behairy BE; El-Araby HA; Abd El Kader HH; Ehsan NA; Salem ME; Zakaria HM; Khedr MA
    Ann Hepatol; 2016; 15(5):682-90. PubMed ID: 27493106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory T Cells in Autoimmune Hepatitis: Unveiling Their Roles in Mouse Models and Patients.
    Wang H; Feng X; Yan W; Tian D
    Front Immunol; 2020; 11():575572. PubMed ID: 33117375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in natural killer cells and exhausted memory regulatory T Cells with corticosteroid therapy in acute autoimmune hepatitis.
    Jeffery HC; Braitch MK; Bagnall C; Hodson J; Jeffery LE; Wawman RE; Wong LL; Birtwistle J; Bartlett H; Lohse AW; Hirschfield GM; Dyson J; Jones D; Hubscher SG; Klenerman P; Adams DH; Oo YH
    Hepatol Commun; 2018 Apr; 2(4):421-436. PubMed ID: 29619420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4
    Qu LM; Wang SH; Yang K; Brigstock DR; Sun L; Gao RP
    Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):133-139. PubMed ID: 29551296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric autoimmune hepatitis shows a disproportionate decline of regulatory T cells in the liver and of IL-2 in the blood of patients undergoing therapy.
    Diestelhorst J; Junge N; Schlue J; Falk CS; Manns MP; Baumann U; Jaeckel E; Taubert R
    PLoS One; 2017; 12(7):e0181107. PubMed ID: 28700730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver injury in acute hepatitis A is associated with decreased frequency of regulatory T cells caused by Fas-mediated apoptosis.
    Choi YS; Lee J; Lee HW; Chang DY; Sung PS; Jung MK; Park JY; Kim JK; Lee JI; Park H; Cheong JY; Suh KS; Kim HJ; Lee JS; Kim KA; Shin EC
    Gut; 2015 Aug; 64(8):1303-13. PubMed ID: 25007815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+ CD25+ Foxp3+ regulatory T cells protect against T cell-mediated fulminant hepatitis in a TGF-beta-dependent manner in mice.
    Wei HX; Chuang YH; Li B; Wei H; Sun R; Moritoki Y; Gershwin ME; Lian ZX; Tian Z
    J Immunol; 2008 Nov; 181(10):7221-9. PubMed ID: 18981144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis.
    Longhi MS; Hussain MJ; Mitry RR; Arora SK; Mieli-Vergani G; Vergani D; Ma Y
    J Immunol; 2006 Apr; 176(7):4484-91. PubMed ID: 16547287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adoptive transfer of ex vivo expanded regulatory T cells in an autoimmune hepatitis murine model restores peripheral tolerance.
    Lapierre P; Béland K; Yang R; Alvarez F
    Hepatology; 2013 Jan; 57(1):217-27. PubMed ID: 22911361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocytes paradoxically affect intrahepatic IFN-γ production in autoimmune hepatitis due to Gal-9 expression and TLR2/4 ligand release.
    Mo R; Feng XX; Wu YN; Wang H; He YP; Sun HH; Guo F; Chen Q; Yan W; Li PY; Liu M; Zhang GM; Tian DA; Feng ZH
    Mol Immunol; 2020 Jul; 123():106-115. PubMed ID: 32485469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.